Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines

Journal of Immunology

Volumn 169, Issue 9, 2002, Pages 4905-4912

  Zeng, Weiguang ^a   Ghosh, Souravi ^a   Lau, Yuk Fai ^a   Brown, Lorena E ^a   Jackson, David C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE VACCINE; CYSTEINE DERIVATIVE; DIPALMITOYL S GLYCERYLCYSTEINE; DIPALMITOYL S GLYCERYLCYSTEINYLSERYLSERINE; EPITOPE; GONADORELIN; INFLUENZA VIRUS HEMAGGLUTININ; LIPID; LIPOPEPTIDE; LYSINE(DIPALMITOYL S GLYCERYLCYSTEINE); LYSINE(DIPALMITOYL S GLYCERYLCYSTEINYLSERYLSERINE); LYSINE(TRIPALMITOYL S GLYCERYLCYSTEINE); SYNTHETIC PEPTIDE; TRIPALMITOYL S GLYCERYLCYSTEINE; TRIPALMITOYL S GLYCERYLCYSTEINYLSERYLSERINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG ACTIVITY; DRUG EFFICACY; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; FEMALE STERILIZATION; HELPER CELL; IMMUNOCONTRACEPTION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0036839103     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.9.4905     Document Type: Article

References (44)

1. Delves, P. J., T. Lund, and I. M. Roitt. 2002. Antifertility vaccines. Trends Immunol. 23:213.
2. Fraser, H. M., A. Gunn, S. L. Jeffcoate, and D. T. Holland. 1974. Effect of active immunization to luteinizing hormone releasing hormone on serum and pituitary gonadotrophins, testes and accessory sex organs in the male rat. J. Endocrinol. 63:399.
3. Fraser, H. M., and T. G. Baker. 1978. Changes in the ovaries of rats after immunization against luteinizing hormone releasing hormone. J. Endocrinol. 77:85.
4. Ferro, V. A., and W. H. Stimson. 1997. Immunoneutralisation of gonadotrophin releasing hormone: A potential treatment for oestrogen-dependent breast cancer. Eur. J. Cancer 33:1468.
5. Talwar, G. P., O. Singh, R. Pal, and N. Chatterjee. 1992. Vaccines for control of fertility and hormone dependent cancers. Int. J. Immunopharmacol. 14:511.
6. Talwar, G. P. 1999. Vaccines and passive immunological approaches for the control of fertility and hormone-dependent cancers. Immunol. Rev. 171:173.
7. Falvo, R. E., V. Chandrashekar, R. D. Arthur, A. R. Kuenstler, T. Hasson, C. Awoniyi, and B. D. Schanbacher. 1986. Effect of active immunization against LHRH or LH in boars: Reproductive consequences and performance traits. J. Anim. Sci. 63:986.
8. Hoskinson, R. M., R. D. Rigby, P. E. Mattner, V. L. Huynh, M. D'Occhio, A. Neish, T. E. Trigg, B. A. Moss, M. J. Lindsey, G. D. Coleman, et al. 1990. Vaxstrate: An anti-reproductive vaccine for cattle. Aust. J. Biotechnol. 4:166.
9. Rovan, E., E. Fiebiger, N. R. Kalla, G. P. Talwar, W. Aulitzky, and J. Frick. 1992. Effect of active immunization to luteinizing-hormone-releasing hormone on the fertility and histoarchitecture of the reproductive organs of male rat. Urol. Res. 20:323.
10. Oonk, H. B., J. A. Turkstra, W. M. Schaaper, J. H. Erkens, M. H. Weerd, A. van Nes, J. H. Verheijden, and R. H. Meloen. 1998. New GnRH-like peptide construct to optimize efficient immunocastration of male pigs by immunoneutralization of GnRH. Vaccine 16:1074.
11. Jung, G., K. H. Wiesmuller, G. Becker, H. J. Buehring, and W. G. Bessler. 1985. Increased production of specific antibodies by presentation of the antigen determinants with covalently coupled lipopeptide mitogens. Angew. Chem. Int. Ed. Engl. 10:872.
12. Martinon, F., H. Gras-Masse, C. Boutillon, F. Chirat, B. Deprez, J. G. Guillet, E. Gomard, A. Tartar, and J. P. Levy. 1992. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant: Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein. J. Immunol. 149:3416.
13. Toyokuni, T., B. Dean, S. Cai, D. Boivin, S. Hakomori, and A. Singhal. 1994. Synthetic vaccines synthesis of a dimeric Tn antigen-lipopeptide conjugate that elicits immune response against Tn-expressing glycoproteins. J. Am. Chem. Soc. 116:395.
14. Deprez, B., H. Gras-Masse, F. Martinon, E. Gomard, J. P. Levy, and A. Tartar. 1995. Pimelautide or trimexautide as built-in adjuvants associated with an HIV1-derived peptide: Synthesis and in vivo induction of antibody and virus-specific cytotoxic T-lymphocyte-mediated response. J. Med. Chem. 38:459.
15. Sauzet, J. P., B. Deprez, F. Martinon, J. G. Guillet, H. Gras-Masse, and E. Gomard. 1995. Long-lasting anti-viral cytotoxic T lymphocytes induced in vivo with chimeric-multirestricted lipopeptides. Vaccine 13:1339.
16. BenMohamed, L., H. Gras-Masse, A. Tartar, P. Daubersies, K. Brahimi, M. Bossus, A. Thomas, and P. Druilhe. 1997. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees. Eur. J. Immunol. 27:1242.
17. Wiesmuller, K. H., G. Jung, and G. Hess. 1989. Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator. Vaccine 7:29.
18. Nardin, E. H., J. M. Calvo-Calle, G. A. Oliveira, P. Clavijo, R. Nussenzweig, R. Simon, W. Zeng, and K. Rose. 1998. Plasmodium falciparum polyoximes: Highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein. Vaccine 16:590.
19. Benmohamed, L., A. Thomas, M. Bossus, K. Brahimi, J. Wubben, H. Gras-Masse, and P. Druilhe. 2000. High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules. Vaccine 18:2843.
20. Obert, M., H. Pleuger, H. G. Hanagarth, J. Schulte-Monting, K. H. Wiesmuller, D. G. Braun, G. Brandner, and R. D. Hess. 1998. Protection of mice against SV40 tumours by Pam3Cys, MTP-PE and Pam3Cys conjugated with the SV40 T antigen-derived peptide, K(698)-T(708). Vaccine 16:161.
21. Deres, K., H. Schild, K. H. Wiesmuller, G. Jung, and H. G. Rammensee. 1989. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342:561.
22. Metzger, J. W., A. G. Beck-Sickinger, M. Loleit, M. Eckert, W. G. Bessler, and G. Jung. 1995. Synthetic S-(2,3-dihydroxypropyl)-cysteinyl peptides derived from the N-terminus of the cytochrome subunit of the photoreaction centre of Rhodopseudornonas viridis enhance murine splenocyte proliferation. J. Pept. Sci. 1:184.
23. Sacht, G., A. Marten, U. Deiters, R. Sussmuth, G. Jung, E. Wingender, and P. F. Muhlradt. 1998. Activation of nuclear factor-κB in macrophages by mycoplasmal lipopeptides. Eur. J. Immunol. 28:4207.
24. Muhlradt, P. F., M. Kiess, H. Meyer, R. Sussmuth, and G. Jung. 1998. Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis. Infect. Immun. 66:4804.
25. Muhlradt, P. F., M. Kiess, H. Meyer, R. Sussmuth, and G. Jung. 1997. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J. Exp. Med. 185:1951.
26. + T cells within the light chain of the H3 hemagglutinin molecule of influenza virus, Virology 198:613.
27. Ghosh, S., and D. C. Jackson. 1999. Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines. Int. Immunol. 11:1103
28. Wiesmuller, K. H., W. Bessler, and G. Jung. 1983. Synthesis of the mitogenic S-[2,3-bis(palmitoyloxy)propyl]-N-palmitoylpentapeptide from Escherichia coli lipoprotein. Hoppe-Seyler's Z. Physiol. Chem. 364:593.
29. Zeng, W., D. C. Jackson, and K. Rose. 1996. Synthesis of a new template with a built-in adjuvant and its use in constructing peptide vaccine candidates through polyoxime chemistry. J. Pept. Sci. 2:66.
30. Jones, A. R. 1975. The metabolism of 3-chloro-, 3-bromo- and 3-iodoprpan-1,2-diol in rats and mice. Xenobiotica 5:155.
31. Metzger, J. W., K. H. Wiesmuller, and G. Jung. 1991. Synthesis of Nα-Fmoc protected derivatives of S-(2,3-dihydroxypropyl)-cysteine and their application in peptide synthesis. Int. J. Pept. Protein Res. 38:545.
32. Jackson, D. C., C. J. Fitzmaurice, L. E. Brown, and W. Zeng. 1999. Preparation and properties of totally synthetic immunogens. Vaccine 18:355.
33. Zeng, W., D. C. Jackson, J. Murray, K. Rose, and L. E. Brown. 2000. Totally synthetic lipid-containing polyoxime peptide constructs are potent immunogens, Vaccine 18:1031.
34. Metzger, J., K. H. Wiesmuller, R. Schaude, W. G. Bessler, and G. Jung. 1991. Synthesis of novel immunologically active tripalmitoyl-S-glycerylcysteinyl lipopeptides as useful intermediates for immunogen preparations. Int. J. Pept. Protein Res. 37:46.
35. Winzler, C., P. Rovere, M. Rescigno, F. Granucci, G. Penna, L. Adorini, V. S. Zimmermann, J. Davoust, and P. Ricciardi-Castagnoli. 1997. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185:317.
36. Ozato, K., N. Mayer, and D. H. Sachs. 1980. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J. Immunol. 124:533.
37. Brown, L. E., J. M. Murray, D. O. White, and D. C. Jackson. 1990. An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin. Arch. Virol. 114:1.
38. Jung, G., and W. G. Bessler. 1995. Lipopeptides as adjuvant and integrated adjuvanticity. In Immunological Recognition of Peptides in Medicine and Biology. N. D. Zegers, W. J. A. Boersma, and E. Claassen, eds. CRC, Boca Raton, FL, p. 159.
39. Nardelli, B., P. B. Haser, and J. P. Tam. 1994. Oral administration of an antigenic synthetic lipopeptide (MAP-P3C) evokes salivary antibodies and systemic humoral and cellular responses. Vaccine 12:1335.
40. Mora, A. L., and J. P. Tam. 1998. Controlled lipidation and encapsulation of peptides as a useful approach to mucosal immunizations. J. Immunol. 161:3616.
41. Huang, W., B. Nardelli, and J. P. Tam. 1994. Lipophilic multiple antigen peptide system for peptide immunogen and synthetic vaccine. Mol. Immunol. 31:1191.
42. Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675.
43. Hertz, C. J., S. M. Kiertscher, P. J. Godowski, D. A. Bouis, M. V. Norgard, M. D. Roth, and R. L. Modlin. 2001. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J. Immunol. 166:2444.
44. Fitzmaurice, C. J., L. E. Brown, V. Kronin, and D. C. Jackson. 2000. The geometry of synthetic peptide-based immunogens affects the efficiency of T cell stimulation by professional antigen-presenting cells. Int. Immunol. 12:527.